Home / Search (Page 5)

risk management - search results

If you're not happy with the results, please do another search
WHO South – East Asia countries has set goals for strengthening its public health coverage

In a meeting today, countries of WHO South-East Asia Region adopted a Ministerial Declaration which resolves to strengthen health system resilience for ensuring health security, achieve Sustainable Development Goals for health, achieve universal health coverage. The member countries committed to reorient health systems towards comprehensive primary health care through increased public […]

WHO South-East Asia Regional Committee meeting begins

The Seventy Fourth Regional Committee meeting of WHO South-East Asia Region, began today with health leaders calling for greater commitment to build resilient health systems and to achieve universal health coverage. “This Session is convened to take important decisions on improving the health status of […]

Prof. M. Habeeb Ghatala Member, Board of Directors Princess Durru Shehvar Children’s & General Hospital Princess Esra Medical Aid Society Senior Consultant Higher Education & Hospital Administration

“I don’t know the key to success, but the key to failure is trying to please everybody” Awards & achievements Life Time Achievement of the Year in the Field of Healthcare Management, Medgate Today, 2016. Life Time Achievement Award, Indus Foundation, 2014. Manager, Ninth World […]

Quality should not be tested in product but it should be built into the product” said Dr. Rubina Bose, Deputy Drugs Controller (India), CDSCO (WZ), Ministry of Health & Family Welfare, Govt. of India

Health and Pharmaceuticals Manufacturing & Medical Devices Committee in association with Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India organized a webinar on Scope of WHO-GMP Certification in Pharmaceutical Industry & Government support. The Guests of Honour of the session were Dr. Rubina […]

Post Feature Image
Cipla launches Cipremi (remdesivir lyophilised powder for injection 100 mg), the only U.S. FDA approved Emergency Use Authorisation (EUA) treatment for patients with severe COVID-19 disease

Cipla Limited (BSE: 500087; NSE: CIPLA EQ, hereinafter referred to as “Cipla”), today announced the launch of remdesivir under its brand name CIPREMI. The U.S. FDA issued an Emergency Use Authorization (EUA) to Gilead Sciences Inc. for emergency use of remdesivir for the treatment of […]